Townson Sharon
Insider CIK 1855689 · GLUE Chief Technology Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-07-06 | 2026-07-07 | 6,000 | — | $0 | 197,290 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-07-06 | 2026-07-07 | 5,600 | $23.25 | $130.2K | 68,245 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-07-06 | 2026-07-07 | 6,000 | $6.14 | $36.8K | 73,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-07-06 | 2026-07-07 | 400 | $24.13 | $9.7K | 67,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-23 | 2026-06-25 | 3,000 | — | $0 | 203,290 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-23 | 2026-06-25 | 3,000 | $20.00 | $60.0K | 67,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-23 | 2026-06-25 | 3,000 | $6.14 | $18.4K | 70,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-06-17 | 2026-06-18 | 3,000 | — | $0 | 206,290 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-06-17 | 2026-06-18 | 3,000 | $19.00 | $57.0K | 67,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-06-17 | 2026-06-18 | 3,000 | $6.14 | $18.4K | 70,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise deriv | 2026-05-29 | 2026-06-01 | 6,000 | — | $0 | 209,290 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-05-29 | 2026-06-01 | 6,000 | $19.87 | $119.2K | 67,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | M Exercise | 2026-05-29 | 2026-06-01 | 6,000 | $6.14 | $36.8K | 73,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | S Sale | 2026-01-05 | 2026-01-05 | 3,155 | $15.17 | $47.9K | 67,845 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2026-01-02 | 2026-01-05 | 158,000 | — | $0 | 158,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2026-01-02 | 2026-01-05 | 35,000 | — | $0 | 71,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2025-01-02 | 2025-01-06 | 161,000 | — | $0 | 161,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award | 2025-01-02 | 2025-01-06 | 36,000 | — | $0 | 36,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2024-06-03 | 2024-06-05 | 40,000 | — | $0 | 40,000 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2023-01-03 | 2023-01-04 | 78,550 | — | $0 | 78,550 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | A Award deriv | 2022-03-01 | 2022-03-02 | 70,000 | — | $0 | 70,000 | SEC↗ |